SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001654954-20-011150
Filing Date
2020-10-14
Accepted
2020-10-14 15:57:06
Documents
1
Period of Report
2020-10-13

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT section16.html 4  
1 PRIMARY DOCUMENT section16.xml 4 3492
  Complete submission text file 0001654954-20-011150.txt   4943
Mailing Address 100 SPY COURT MARKHAM A6 L3R 5H6
Business Address 100 SPY COURT MARKHAM A6 L3R 5H6 (905) 475-1234
Edesa Biotech, Inc. (Issuer) CIK: 0001540159 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O STELLAR BIOTECHNOLOGIES, INC. 332 EAST SCOTT STREET PORT HUENEME CA 93041
Business Address
OAKES FRANK R. (Reporting) CIK: 0001620188 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37619 | Film No.: 201239056